4.1
Dystrybucja leków: Przegląd
Dystrybucja leków w organizmie to dynamiczny proces obejmujący przemieszczanie się leku w dwóch kierunkach przez różne przedziały: z krwiobiegu do tka…
Dystrybucja odnosi się do dwukierunkowego przemieszczania się leku między różnymi przedziałami w ciele.
Jest to proces pasywny napędzany gradientem stężeń między krwią a tkankami pozanaczyniowymi.
Początkowo wolny lek we krwi szybko przenika przez ściany naczyń włosowatych i dostaje się do płynu zewnątrzkomórkowego lub ECF.
Stamtąd przechodzi przez błonę komórkową tkanki, aby dotrzeć do płynu wewnątrzkomórkowego.
Ten krok jest krokiem ograniczającym szybkość i opiera się na dwóch głównych czynnikach. Pierwszym z nich jest szybkość perfuzji do tkanki zewnątrzkomórkowej, która określa, jak szybko lek jest dostarczany do tkanki.
Drugim jest przepuszczalność błony leku. Decyduje o tym, jak łatwo lek może przenikać przez błonę komórkową.
Inne czynniki wpływające na dystrybucję leków to wielkość narządów lub tkanek, bariery fizjologiczne i osoby.
Teoretyczna objętość płynu ustrojowego, do którego rozprowadzany jest lek, jest zilustrowana objętością dystrybucji.
View the full transcript and gain access to JoVE Core videos
Q1: What is drug distribution and how does it work in the body?
Drug distribution is the two-way movement of a drug between different body compartments, driven by concentration gradients. Free drug in the blood passively permeates capillary walls and enters the extracellular fluid. From there, it crosses cell membranes to reach intracellular fluid. This process is passive and relies on the concentration difference between blood and tissues to move drugs throughout the body.
Q2: Why is crossing the cell membrane the rate-limiting step in drug distribution?
Crossing the cell membrane is the rate-limiting step because it determines how quickly a drug reaches its site of action inside cells. Two factors control this step: perfusion rate, which determines how fast the drug reaches tissue, and membrane permeability, which dictates how easily the drug crosses the cell membrane. Together, these factors govern the overall speed of drug distribution throughout the body.
Q3: How does plasma protein binding affect drug distribution?
Drugs bound to plasma proteins like albumin become inactive and cannot cross cell membranes, limiting their availability for tissue uptake. Only free, unbound drug can distribute into tissues. This binding significantly restricts how much active drug reaches target cells, making protein binding a critical factor in determining drug distribution patterns and therapeutic effectiveness.
Q4: What role do physiological barriers play in drug distribution?
Physiological barriers like the blood-brain barrier restrict passage of certain substances, protecting sensitive organs such as the brain. These barriers limit which drugs can reach specific tissues, affecting overall distribution patterns. Individual differences in barrier function and drug characteristics determine whether a drug can cross these protective boundaries to reach its target tissue.
Q5: How does tissue release occur after drug distribution?
Tissue release occurs when drug concentrations in the bloodstream decrease due to metabolism or elimination, creating a reverse concentration gradient. Drugs diffuse back from tissues into the blood, driven by this concentration difference. The tissue's affinity for the drug, presence of binding proteins, and the drug's ability to diffuse through membranes all influence the rate of tissue release.
Q6: What factors besides perfusion and permeability influence drug distribution?
Organ or tissue size impacts how much drug can be accommodated, while individual differences such as genetic variations, metabolism rates, and overall health influence distribution patterns. These factors work alongside perfusion rate and membrane permeability to determine the final distribution of a drug throughout the body and its therapeutic effectiveness.
Q7: What does volume of distribution represent in pharmacokinetics?
Volume of distribution is a hypothetical volume representing the body fluid space where a drug disperses to achieve the observed blood concentration. It quantifies the extent of drug distribution within the body and helps predict how widely a drug spreads. A larger volume of distribution indicates the drug distributes extensively into tissues, while a smaller volume suggests limited tissue penetration.